
June 12 (Reuters) - Quince Therapeutics Inc QNCX.O:
QUINCE THERAPEUTICS ANNOUNCES PRICING OF UP TO $22 MILLION PRIVATE PLACEMENT OF SECURITIES
QUINCE THERAPEUTICS INC - FINANCING TO PROVIDE $11.5 MILLION UPFRONT, $10.4 MILLION FROM WARRANTS
QUINCE THERAPEUTICS INC - PROCEEDS TO FUND PHASE 3 NEAT TRIAL AND CORPORATE PURPOSES
QUINCE THERAPEUTICS INC - PROCEEDS EXPECTED TO FUND OPERATIONS INTO SECOND QUARTER 2026